Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Privia Health Group Inc shares valued at $390,089 were sold by Mehrotra Parth on May 13 ’25. At $24.52 per share, Mehrotra Parth sold 15,909 shares. The insider’s holdings dropped to 407,234 shares worth approximately $8.96 million following the completion of this transaction.
Also, Mehrotra Parth sold 13,773 shares, netting a total of over 344,187 in proceeds. Following the sale of shares at $24.99 each, the insider now holds 423,143 shares.
Before that, Mountcastle David had sold 3,322 shares from its account. In a trade valued at $83,017, the EVP & Chief Financial Officer traded Privia Health Group Inc shares for $24.99 each. Upon closing the transaction, the insider’s holdings decreased to 3,322 shares, worth approximately $3.8 million.
As published in their initiating research note from Needham on January 10, 2025, Privia Health Group Inc [PRVA] has been a Buy and the price target has been revised to $25. Analysts at Macquarie started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid December. As of October 11, 2024, KeyBanc Capital Markets has initiated its “an Overweight” rating for PRVA. Earlier on May 30, 2024, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for PRVA stock.
Analyzing PRVA Stock Performance
On last trading session,, Privia Health Group Inc [NASDAQ: PRVA] rose 1.15% to $22.0. The stock’s lowest price that day was $21.5501, but it reached a high of $22.24 in the same session. During the last five days, there has been a surge of approximately 0.87%. Over the course of the year, Privia Health Group Inc shares have jumped approximately 30.49%. Shares of the company reached a 52-week high of $26.09 on 05/08/25 and a 52-week low of $19.47 on 01/02/25.
Support And Resistance Levels for Privia Health Group Inc (PRVA)
According to the 24-hour chart, there is a support level at 21.55, which, if violated, would cause prices to drop to 21.10. In the upper region, resistance lies at 22.45. The next price resistance is at 22.90. RSI (Relative Strength Index) is 40.70 on the 14-day chart, showing neutral technical sentiment.
Is Privia Health Group Inc subject to short interest?
Stocks of Privia Health Group Inc saw a sharp steep in short interest on 2025-06-13 dropping by -0.13 million shares to 3.43 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 3.56 million shares. A decline of -3.91% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.71 of the overall float, the days-to-cover ratio (short ratio) decline to 4.71.
Which companies own the most shares of Privia Health Group Inc (PRVA)?
In terms of Privia Health Group Inc share price expectations, FactSet research, analysts set an average price target of 29 in the next 12 months, up nearly 33.33% from the previous closing price of $21.75. Analysts anticipate Privia Health Group Inc stock to reach 40 by 2025, with the lowest price target being 25. In spite of this, 10 analysts ranked Privia Health Group Inc stock as Buy at the end of 2025. On April 22, 2024, Citigroup assigned a price target of “a Buy” to the stock and initiated coverage with a $25.
